The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy

Clinical and Experimental Nephrology

Volumn 16, Issue 5, 2012, Pages 713-721

  Obara, Takashi ^a   Mizoguchi, Sadaaki ^a   Shimozuru, Yasunori ^a   Sato, Toshitaka ^a   Hotta, Osamu ^b  

^a EISAI CO LTD   (Japan)

^b Hotta Osamu Clinic   (Japan)

Author keywords

Diagnosis; ELISA; IgA nephropathy; Immune complex; Uromodulin

Indexed keywords

IMMUNOGLOBULIN A; TAMM HORSFALL GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NON INVASIVE MEASUREMENT; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINALYSIS; WESTERN BLOTTING;

ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MULTIPROTEIN COMPLEXES; SENSITIVITY AND SPECIFICITY; UROMODULIN;

EID: 84868354902     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0617-3     Document Type: Article

References (24)

1. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Group on progressive renal diseases. Am J Kidney Dis. 1997;4:526-32.
2. Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Roccatello D, et al. Incidence of biopsy-proven primary glomerulonephritis in Italian province. Am J Kidney Dis. 1996;27:631-9.
3. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore). 1985;64:49-60.
4. Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L. Natural history of IgAN in patients followed up for more than ten years in Spain. Semin Nephrol. 1987;7:346-50.
5. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996;334:939-45.
6. Locatelli F. Antiproteinuric effect of losartan in patients with chronic renal disease. Nephrol Dial Transplant. 1997;12:2204-5.
7. Wardle EN. Dipyridamole in the nephritides. Am J Ther. 1998;5:107-9.
8. Schena P, Montenegro M, Scibittaro V. Meta-analysis of randomized controlled trials in patients with primary IgA nephropathy. Nephrol Dial Transplant. 1990;1:47-52.
9. Bennet WM, Walker RG, Kinkid-Smith P. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial. Clin Nephrol. 1989;31:128-31.
10. Hotta O, Taguma Y, Kurosawa K, Matsutani S. Early intensive therapy for clinical remission of active IgA nephropathy: a threeyear follow-up study. Japan J Nephrol. 1993;35:81-7.
11. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736-43.
12. Sato M, Hotta O, Tomioka S, Horigome I, Chiba S, Miyazaki M, et al. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract. 2003;93:c137-45.
13. Wong Y, Chen J, Wang Y, Chen Y, Wang L, Lv Y. A metaanalysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:1923-31.
14. Kokubo T, Hiki Y, Iwase H, Tanaka A, Toma K, Hotta K, et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol. 1998;9:2048-54.
15. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313-20.
16. Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, et al. Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun Mass Spectrom. 2010;24:1971-8.
17. Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, et al. IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant. 2006;21:2478-84.
18. Katayama H, Tabata T, Ishihama Y, Sato T, Oda Y, Nagasu T. Efficient in-gel digestion procedure using 5-cyclohexyl-1-pentylb-D-maltoside as an additive for gel-based membrane proteomics. Rapid Commun Mass Spectorom. 2004;18:2388-94.
19. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, et al. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem. 1986;32:1551-4.
20. Lau WH, Leong WS, Ismail Z, Gam LH. Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease. Int J Biol Sci. 2008;4:215-22.
21. Siao SC, Li KJ, Hsieh SC, Wu CH, Lu MC, Tsai CY, et al. Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway. Molecules. 2011;16:2119-34.
22. Vizjak A, Trnacević S, Ferluga D, Halilbasić A. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. IV. Immunohistology. Kidney Int Suppl. 1991;34:S68-74.
23. Machii R, Matsuda K, Hiratsuka N, Sugimoto K, Hotta O, Itoh Y, et al. Analysis of an expanded width of albumin fraction by cellulose acetate membrane electrophoresis in IgA nephropathy urine before treatment. J Clin Lab Anal. 2003;17:37-43.
24. Hotta O. Treatment of IgA nephropathy. In: Kai KN, editor. Recent advances in IgA nephropathy. World Scientific; 2009. p. 369-86.